In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Avon celebrated the brand’s latest innovation, ANEW Clinical Pro Line Eraser Treatment, with flash mobs coast to coast in five cities, including New York, Chicago, Atlanta, Dallas and Los Angeles. Professional ballroom dancer Karina Smirnoff led the moves and wowed the crowd in Los Angeles. Avon Representatives in all cities joined in on the flash mobs and distributed tens of thousands of samples of ANEW Clinical Pro Line Eraser Treatment, which launches this month across the country.
“I can never turn down an opportunity to dance—especially when it’s celebrating such an exciting new innovation like Pro Line Eraser Treatment,” says Smirnoff. “I’m so thrilled to be a part of this big moment for Avon and spending time with the Representatives and fans.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/52897-avon-anew-clinical-pro-line-eraser-treatment-skincare-dermatology
Stiefel, a GSK company, announced today that Hats On For Skin Health, its global campaign with the International League of Dermatological Societies (ILDS), has raised enough funds to produce 15,000 sun-protective hats for albinos living in East Africa and has already distributed more than 2,000 hats. The hats are being distributed from Tanzania, where estimates are that 98 percent of albino children will die before the age of 40 from cancers of the skin – a direct result of the sun’s damaging rays. Worldwide, albinism affects about one in 20,000 people. However the incidence of albinism in Sub-Saharan Africa is significantly higher than in the rest of the world, specifically in Tanzania where the incidence is one in 1,429.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55030-stiefel-gsk-ilds-hats-on-for-skin-health-campaign-east-africa
Avon Products Inc. today officially announced a breakthrough anti-aging sun care collection — ANEW Solar Advance with RepairShield™ Technology. The research behind this revolutionary line was unveiled at the American Academy of Dermatology’s 69th annual meeting. The ANEW Solar Advance anti-aging sun care line not only provides superior protection against the sun’s damaging rays with photostable broad-spectrum UVA/UVB protection, but is also designed to repair skin cell sun damage.* Patented RepairShield Technology™ is designed to protect skin by stimulating its natural antioxidant defense system to fight free radicals and to repair by activating skin’s natural repair process.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42980/
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
